Читать книгу National Biodefense Strategy - White House - Страница 11

Table of Contents

The National Biodefense Strategy has five goals with associated objectives for strengthening the biodefense enterprise, establishing a layered risk management approach to countering biological threats and incidents.

Goal 1: Enable Risk Awareness to Inform Decision-making Across the Biodefense Enterprise. The United States will build risk awareness at the strategic level, through analyses and research efforts to characterize deliberate, accidental, and natural biological risks; and at the operational level, through surveillance and detection activities to detect and identify biological threats and anticipate biological incidents.

Objectives:

1.1: Ensure decision-making is informed by intelligence, forecasting, and risk assessment

1.2: Ensure that domestic and international biosurveillance and information-sharing systems are coordinated and are capable of timely bioincident prevention, detection, assessment, response, and recovery.

Goal 2: Ensure Biodefense Enterprise Capabilities to Prevent Bioincidents. The United States will work to prevent the outbreak and spread of naturally occurring disease, and minimize the chances of laboratory accidents. The United States will also strengthen biosecurity to prevent hostile actors from obtaining or using biological material, equipment, and expertise for nefarious purposes, consistent with the United States Govermenent’s approach to countering weapons of mass destruction (WMD) terrorism. Goal 2 will ensure we have the capabilities necessary to disrupt plots, degrade technical capabilities, and deter support for terrorists seeking to use WMD. This goal also recognizes the "dual use" natures of the life sciences and biotechnology, in which the same science and technology base that improves health, promotes innovation, and protects the environment, can also be misused to facilitate a biological attack. The United States seeks to prevent the misuse of science and technology while promoting and enhancing legitimate use and innovation.